Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp378 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Role of Wnt antagonists (sclerostin and Dkk-1) on bone turnover markers and bone mass, in patients with complete spinal cord injury: preliminary results

Gifre Laia , Vidal Joan , Ruiz-Gaspa Silvia , Portell Enric , Monegal Ana , Muxi Africa , Guanabens Nuria , Peris Pilar

Spinal cord injury (SCI) has been associated with a marked increase in bone loss. This study analysed the effect of Wnt signalling antagonists (sclerostin and DKK-1) and their relationship with bone turnover markers and BMD evolution in patients with a recent SCI.Methods: Patients with a recent complete motor SCI (AIS A or B); (<6 months) were prospectively included. Bone turnover markers (bone formation: P1NP, bone AP; bone resorption: sCTx), Wnt an...

ba0003pp371 | Other diseases of bone and mineral metabolism | ECTS2014

Effect of complete spinal cord injury on bone turnover and bone mineral density evolution: a 1 year follow-up study

Gifre Laia , Vidal Joan , Ruiz-Gaspa Silvia , Portell Enric , Monegal Ana , Muxi Africa , Guanabens Nuria , Peris Pilar

Spinal cord injury (SCI) has been associated with marked bone loss and an increased risk of fractures under the SCI level. The aim of the study was to analyze the effect of recent complete SCI on bone turnover and bone mineral density (BMD) evolution and factors related to bone loss.Methods: Prospective study including patients with complete motor SCI (ASIA A or B) (<6 months). Bone turnover markers (bone formation: P1NP, bone ALP and resorption: sCT...

ba0005p366 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and antiosteoporotic response to denosumab therapy: preliminary results

Gifre Laia , Vidal Joan , Ruiz-Gaspa Silvia , Portell Enric , Monegal Ana , Muxi Africa , Guanabens Nuria , Peris Pilar

The aims of this study were to analyze the role of the regulators of bone remodeling, OPG and RANKL, in the bone loss associated with recent spinal cord injury (SCI) as well as the effect of antiosteoporotic therapy with denosumab in these bone regulators in a prospective study.Patients and methods: Twenty-three male patients (aged 18–67 years (mean 36±16 years)) with recent (<6 months) complete SCI were prospectively included (43.5% parapl...

ba0005p44 | Bone development/growth and fracture repair | ECTS2016

Effect of a mixture of GOS/FOS® on calcium (Ca) and phosphorus (P) absorption and bone retention in ovariectomized osteopenic rats fed a low calcium diet

Bryk Gabriel , Coronel Magali Zeni , de Portela Maria Luz Pita Martin , Zeni Susana Noemi

Dietary Ca insufficiency is a common finding, independently of socio-economic status. A low Ca intake (CaI) increases bone turnover leading to bone loss. This effect becomes more important during estrogen withdrawing. We previously found that a mixture of galactooligosaccharides (GOS) and fructooligosaccharides (FOS) enhances Ca and P absorption (Abs), being a suitable tool to optimize its bioavailability and consequently bone health. The present study evaluated the effect of ...

ba0001pp99 | Calciotropic and phosphotropic hormones and mineral metabolism | ECTS2013

Interrelationship between osteocalcin (bgp) and energetic metabolism in two strains of rats

Marotte Clarisa , Bryk Gabriel , Coronel Magali Zeni , Abrego Paulina , Lucero Diego Martin , Schreier Laura , Portela Maria Luz , Zeni Susana Noemi

It has suggested that BGP is inversely related to body fat. BGP appears to regulate energetic metabolism through the insulin receptor signaling pathway in the osteoblast, which affects bone resorption and BGP activity. Fat tissue is an endocrine organ that secretes different hormones and growth factors; several of them affect bone remodeling and insulin secretion. The present report comparatively studied total BGP levels, glucose homeostasis and body fat mass in spontaneous ob...

ba0001pp100 | Calciotropic and phosphotropic hormones and mineral metabolism | ECTS2013

A mixture of GOS/FOS ® added to a low calcium (ca) diet improved ca, phosphorus (p) and magnesium (mg) absorption: experimental model in normal growing rats

Bryk Gabriel , Chaves Macarena Gonzales , Marotte Clarisa , Medina Daniela , Coronel Magali Zeni , de Portela Maria Luz , Zeni Susana Noemi

A mixture of Galacto-oligosaccharides (GOS) and Fructooligosaccharides (FOS) are added to commercial infant formula to promote an intestinal microbiota similar to that prevalent in breast-fed infants to improve Ca bioavailability and general health, but their mechanisms are under debate.Our objective was to evaluate the beneficial effects of the mixture of GOS/FOS added to infant formulae, on the absorption of Ca, Mg and P of a low Ca diet. Changes in in...

ba0003pp408 | Paediatric bone disease | ECTS2014

Effect of GOS/FOS on calcium and phosphorus absorption and retention during recovering from undernutrition: experimental model in normal growing rats

Bryk Gabriel , Coronel Magali Zeni , Medina Daniela , Mandalunis Patricia , de Portela Maria Luz Pita Martin , Susana Zeni

During early life undernutrition impairs normal weight and height gain that affects bone health. During recovering it is required an extra-amount of Ca to ensure the high demands of bone mineralization. A mixture of galactooligosaccharides (GOS) and fructooligosaccharides (FOS) would be a useful tool to increase mineral intestinal absorption to enhancing the amount of Ca to be retained into bone. Our objective was to evaluate, in an experimental model of protein restriction (P...